These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7603201)

  • 21. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.
    Moore N; Kreft-Jais C; Haramburu F; Noblet C; Andrejak M; Ollagnier M; Bégaud B
    Br J Clin Pharmacol; 1997 Nov; 44(5):513-8. PubMed ID: 9384470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
    Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
    Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
    McLaughlin DM; Atkinson AB; Ennis CN; Browne J; Hunter SJ; Sheridan B; Bell PM
    Diabet Med; 2008 May; 25(5):631-4. PubMed ID: 18445178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blunted adrenocorticotrophic hormone release during captopril treatment.
    Dessì-Fulgheri P; Alagna S; Madeddu P; Glorioso N; Masala A; Rovasio PP; Leoni C; Rappelli A
    J Hypertens Suppl; 1985 Nov; 3(2):S125-7. PubMed ID: 3003300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    JAMA; 1997 Jul; 278(1):40-3. PubMed ID: 9207336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avoidance of ACE inhibitors or angiotensin receptor blockers among women of childbearing potential with diabetes.
    Guirguis AB; Shilliday BB; Malone RM; Pignone MP
    Diabetes Res Clin Pract; 2008 Jan; 79(1):e11-2. PubMed ID: 17716774
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
    Webster J; Murchison LE; Robb OJ
    Scott Med J; 1988 Apr; 33(2):247-8. PubMed ID: 2840738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril does not affect reflex increases in adrenal or lumbar sympathetic nerve activity to hypoglycemia in rats.
    Muntzel MS; Joseph T; Onwumere O
    Metabolism; 2005 Dec; 54(12):1679-86. PubMed ID: 16311103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced hypoglycaemia in type 2 diabetes.
    Inkster B; Zammitt NN; Frier BM
    Expert Opin Drug Saf; 2012 Jul; 11(4):597-614. PubMed ID: 22690846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.
    de Galan BE; Simsek S; Tack CJ; Heine RJ
    Neth J Med; 2006 Oct; 64(9):319-25. PubMed ID: 17057268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment strategy for elderly diabetic patient with insulin or GLP-1 receptor agonist].
    Ando Y
    Nihon Rinsho; 2013 Nov; 71(11):1993-8. PubMed ID: 24397172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
    Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled insulin: new technology, new possibilities.
    Bellary S; Barnett AH
    Int J Clin Pract; 2006 Jun; 60(6):728-34. PubMed ID: 16805759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin via continuous subcutaneous infusion.
    Pickup JC; Keen H; Stevenson RW; Parsons JA; Alberti KG; White M; Kohner EM
    Lancet; 1978 Nov; 2(8097):988-9. PubMed ID: 82007
    [No Abstract]   [Full Text] [Related]  

  • 39. ACE inhibitors as initial therapy for hypertension.
    Schoenberger JA
    Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interaction between converting enzyme inhibitors and hypoglycemic sulfonamides or insulin].
    Girardin E; Raccah D
    Presse Med; 1998 Nov; 27(37):1914-23. PubMed ID: 9858970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.